At AACR, Revolution Medicines presented more eye-catching data about its KRAS-targeting treatment, and Anthony Letai declared the state of cancer research steady.
Lawmakers seem poised to reject cuts to biomedical research and public health spending for a second straight year.
Health insurers would likely face a financial strain by participating in the Medicare pilot.
The U.S. government is the largest donor to global health in the world. This fact sheet breaks down the U.S. global health budget by program area: HIV/PEPFAR; tuberculosis; malaria/the President's…
Section 1115 Medicaid waivers can allow states to test new approaches in Medicaid that differ from what is required by federal law. This page tracks approved and pending waiver provisions…
We'll be zeroed in on Kennedy's exchanges with one doc in particular: Bill Cassidy.
A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the Justice Department on Tuesday, clearing the way for the company to finalize a settlement…
BioAge bets on inflammation, a short Pfizer career, and more biotech news from The Readout
A U.S. judge is expected to direct Purdue Pharma to forfeit $225 million to the Justice Department, clearing the way for a massive settlement
To kick off KFF’s Business of Health with Chip Kahn, KFF’s Drew Altman explains how KFF is continually evolving to research, analyze and lead on health policy. Chip and Drew…